An Open-label, Randomized, Phase 3 Clinical Trial of ABX-EGF Plus Best Supportive Care Versus Best Supportive Care in Subjects With Metastatic Colorectal Cancer.
Phase of Trial: Phase III
Latest Information Update: 01 Oct 2016
At a glance
- Drugs Panitumumab (Primary)
- Indications Colorectal cancer
- Focus Biomarker; Pharmacogenomic; Registrational; Therapeutic Use
- Sponsors Amgen
- 04 Jun 2013 Results presented at the 49th Annual Meeting of the American Society of Clinical Oncology.
- 07 Jun 2011 Pharmacogenomic analysis results presented at the 47th Annual Meeting of the American Society of Clinical Oncology.
- 01 Feb 2011 Health-related quality of life and colorectal cancer-specific symptom results published in the International Journal of Colorectal Disease.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History